Looking east, Sanofi pens 'pioneering' cancer drug partnership with China's Innovent

When it comes to global market expansion, many Big Pharmas have their eye on China—and clearly Sanofi is no exception.

The French drugmaker has signed a cancer-focused deal with Suzhou-based Innovent with a goal of developing and rolling out two of Sanofi’s oncology assets.